世界の静脈血栓塞栓症（VTE）治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Venous thromboembolism(VTE)Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5897 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、静脈血栓塞栓症（VTE）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（深部静脈血栓症（DVT）、肺塞栓症（PE）、その他）、用途別市場規模（病院、外来手術センター、研究所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・静脈血栓塞栓症（VTE）治療薬の市場動向 ・企業の競争状況、市場シェア ・静脈血栓塞栓症（VTE）治療薬の種類別市場規模（深部静脈血栓症（DVT）、肺塞栓症（PE）、その他） ・静脈血栓塞栓症（VTE）治療薬の用途別市場規模（病院、外来手術センター、研究所、その他） ・静脈血栓塞栓症（VTE）治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・静脈血栓塞栓症（VTE）治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・静脈血栓塞栓症（VTE）治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・静脈血栓塞栓症（VTE）治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・静脈血栓塞栓症（VTE）治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Boehringer Ingelheim、Bayer、Janssen、Bristol-Myers Squibb、Pfizer、Daiichi-Sankyo、Portola Pharmaceuticals、Armetheon） ・結論

Venous thromboembolism (VTE), which is composed of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the circulatory system that leads to impeded blood flow, which can have serious consequences in the affected individual (Heit, 2015). In VTE, a DVT is a clot that occurs only in the veins; generally, they occur in the deep veins of the legs and pelvis, but may also occur in the veins of the upper body (AHA, 2017; Cohen et al., 2007; Heit, 2015). The clot may break off from its original location and travel throughout the circulatory system, and if the clot ends up in the lung, it is known as a PE 
One of the Major drivers of VTE market growth over the forecast period is the increase in patient shares towards the NOACs due to increased confidence among physicians about using these novel therapies.

Market Analysis and Insights: Global Venous thromboembolism(VTE)Therapeutics Market
The global Venous thromboembolism(VTE)Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Venous thromboembolism(VTE)Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Venous thromboembolism(VTE)Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Venous thromboembolism(VTE)Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Venous thromboembolism(VTE)Therapeutics market.

Global Venous thromboembolism(VTE)Therapeutics Scope and Market Size
Venous thromboembolism(VTE)Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Venous thromboembolism(VTE)Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Deep Vein Thrombosis(DVT)
Pulmonary Embolism(PE)
Others

Segment by Application
Hospital
Ambulatory Surgery Centers
Research Institutes
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Boehringer Ingelheim
Bayer
Janssen
Bristol-Myers Squibb
Pfizer
Daiichi-Sankyo
Portola Pharmaceuticals
Armetheon

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Venous thromboembolism(VTE)Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Deep Vein Thrombosis(DVT)
1.2.3 Pulmonary Embolism(PE)
1.2.4 Others
1.3 Market by Application
1.3.1 Global Venous thromboembolism(VTE)Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Ambulatory Surgery Centers
1.3.4 Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Venous thromboembolism(VTE)Therapeutics Market Perspective (2016-2027)
2.2 Venous thromboembolism(VTE)Therapeutics Growth Trends by Regions
2.2.1 Venous thromboembolism(VTE)Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Venous thromboembolism(VTE)Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Venous thromboembolism(VTE)Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Venous thromboembolism(VTE)Therapeutics Industry Dynamic
2.3.1 Venous thromboembolism(VTE)Therapeutics Market Trends
2.3.2 Venous thromboembolism(VTE)Therapeutics Market Drivers
2.3.3 Venous thromboembolism(VTE)Therapeutics Market Challenges
2.3.4 Venous thromboembolism(VTE)Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Venous thromboembolism(VTE)Therapeutics Players by Revenue
3.1.1 Global Top Venous thromboembolism(VTE)Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Venous thromboembolism(VTE)Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Venous thromboembolism(VTE)Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Venous thromboembolism(VTE)Therapeutics Revenue
3.4 Global Venous thromboembolism(VTE)Therapeutics Market Concentration Ratio
3.4.1 Global Venous thromboembolism(VTE)Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Venous thromboembolism(VTE)Therapeutics Revenue in 2020
3.5 Venous thromboembolism(VTE)Therapeutics Key Players Head office and Area Served
3.6 Key Players Venous thromboembolism(VTE)Therapeutics Product Solution and Service
3.7 Date of Enter into Venous thromboembolism(VTE)Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Venous thromboembolism(VTE)Therapeutics Breakdown Data by Type
4.1 Global Venous thromboembolism(VTE)Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Venous thromboembolism(VTE)Therapeutics Forecasted Market Size by Type (2022-2027)

5 Venous thromboembolism(VTE)Therapeutics Breakdown Data by Application
5.1 Global Venous thromboembolism(VTE)Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Venous thromboembolism(VTE)Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Venous thromboembolism(VTE)Therapeutics Market Size (2016-2027)
6.2 North America Venous thromboembolism(VTE)Therapeutics Market Size by Type
6.2.1 North America Venous thromboembolism(VTE)Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Venous thromboembolism(VTE)Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Venous thromboembolism(VTE)Therapeutics Market Size by Type (2016-2027)
6.3 North America Venous thromboembolism(VTE)Therapeutics Market Size by Application
6.3.1 North America Venous thromboembolism(VTE)Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Venous thromboembolism(VTE)Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Venous thromboembolism(VTE)Therapeutics Market Size by Application (2016-2027)
6.4 North America Venous thromboembolism(VTE)Therapeutics Market Size by Country
6.4.1 North America Venous thromboembolism(VTE)Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Venous thromboembolism(VTE)Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Venous thromboembolism(VTE)Therapeutics Market Size (2016-2027)
7.2 Europe Venous thromboembolism(VTE)Therapeutics Market Size by Type
7.2.1 Europe Venous thromboembolism(VTE)Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Venous thromboembolism(VTE)Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Venous thromboembolism(VTE)Therapeutics Market Size by Type (2016-2027)
7.3 Europe Venous thromboembolism(VTE)Therapeutics Market Size by Application
7.3.1 Europe Venous thromboembolism(VTE)Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Venous thromboembolism(VTE)Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Venous thromboembolism(VTE)Therapeutics Market Size by Application (2016-2027)
7.4 Europe Venous thromboembolism(VTE)Therapeutics Market Size by Country
7.4.1 Europe Venous thromboembolism(VTE)Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Venous thromboembolism(VTE)Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Venous thromboembolism(VTE)Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Venous thromboembolism(VTE)Therapeutics Market Size by Type
8.2.1 Asia-Pacific Venous thromboembolism(VTE)Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Venous thromboembolism(VTE)Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Venous thromboembolism(VTE)Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Venous thromboembolism(VTE)Therapeutics Market Size by Application
8.3.1 Asia-Pacific Venous thromboembolism(VTE)Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Venous thromboembolism(VTE)Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Venous thromboembolism(VTE)Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Venous thromboembolism(VTE)Therapeutics Market Size by Region
8.4.1 Asia-Pacific Venous thromboembolism(VTE)Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Venous thromboembolism(VTE)Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Venous thromboembolism(VTE)Therapeutics Market Size (2016-2027)
9.2 Latin America Venous thromboembolism(VTE)Therapeutics Market Size by Type
9.2.1 Latin America Venous thromboembolism(VTE)Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Venous thromboembolism(VTE)Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Venous thromboembolism(VTE)Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Venous thromboembolism(VTE)Therapeutics Market Size by Application
9.3.1 Latin America Venous thromboembolism(VTE)Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Venous thromboembolism(VTE)Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Venous thromboembolism(VTE)Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Venous thromboembolism(VTE)Therapeutics Market Size by Country
9.4.1 Latin America Venous thromboembolism(VTE)Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Venous thromboembolism(VTE)Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Venous thromboembolism(VTE)Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Venous thromboembolism(VTE)Therapeutics Market Size by Type
10.2.1 Middle East & Africa Venous thromboembolism(VTE)Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Venous thromboembolism(VTE)Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Venous thromboembolism(VTE)Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Venous thromboembolism(VTE)Therapeutics Market Size by Application
10.3.1 Middle East & Africa Venous thromboembolism(VTE)Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Venous thromboembolism(VTE)Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Venous thromboembolism(VTE)Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Venous thromboembolism(VTE)Therapeutics Market Size by Country
10.4.1 Middle East & Africa Venous thromboembolism(VTE)Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Venous thromboembolism(VTE)Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Details
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Venous thromboembolism(VTE)Therapeutics Introduction
11.1.4 Boehringer Ingelheim Revenue in Venous thromboembolism(VTE)Therapeutics Business (2016-2021)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Venous thromboembolism(VTE)Therapeutics Introduction
11.2.4 Bayer Revenue in Venous thromboembolism(VTE)Therapeutics Business (2016-2021)
11.2.5 Bayer Recent Development
11.3 Janssen
11.3.1 Janssen Company Details
11.3.2 Janssen Business Overview
11.3.3 Janssen Venous thromboembolism(VTE)Therapeutics Introduction
11.3.4 Janssen Revenue in Venous thromboembolism(VTE)Therapeutics Business (2016-2021)
11.3.5 Janssen Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Venous thromboembolism(VTE)Therapeutics Introduction
11.4.4 Bristol-Myers Squibb Revenue in Venous thromboembolism(VTE)Therapeutics Business (2016-2021)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Venous thromboembolism(VTE)Therapeutics Introduction
11.5.4 Pfizer Revenue in Venous thromboembolism(VTE)Therapeutics Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Daiichi-Sankyo
11.6.1 Daiichi-Sankyo Company Details
11.6.2 Daiichi-Sankyo Business Overview
11.6.3 Daiichi-Sankyo Venous thromboembolism(VTE)Therapeutics Introduction
11.6.4 Daiichi-Sankyo Revenue in Venous thromboembolism(VTE)Therapeutics Business (2016-2021)
11.6.5 Daiichi-Sankyo Recent Development
11.7 Portola Pharmaceuticals
11.7.1 Portola Pharmaceuticals Company Details
11.7.2 Portola Pharmaceuticals Business Overview
11.7.3 Portola Pharmaceuticals Venous thromboembolism(VTE)Therapeutics Introduction
11.7.4 Portola Pharmaceuticals Revenue in Venous thromboembolism(VTE)Therapeutics Business (2016-2021)
11.7.5 Portola Pharmaceuticals Recent Development
11.8 Armetheon
11.8.1 Armetheon Company Details
11.8.2 Armetheon Business Overview
11.8.3 Armetheon Venous thromboembolism(VTE)Therapeutics Introduction
11.8.4 Armetheon Revenue in Venous thromboembolism(VTE)Therapeutics Business (2016-2021)
11.8.5 Armetheon Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Venous thromboembolism(VTE)Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Deep Vein Thrombosis(DVT)
Table 3. Key Players of Pulmonary Embolism(PE)
Table 4. Key Players of Others
Table 5. Global Venous thromboembolism(VTE)Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Venous thromboembolism(VTE)Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Venous thromboembolism(VTE)Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Venous thromboembolism(VTE)Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Venous thromboembolism(VTE)Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Venous thromboembolism(VTE)Therapeutics Market Share by Regions (2022-2027)
Table 11. Venous thromboembolism(VTE)Therapeutics Market Trends
Table 12. Venous thromboembolism(VTE)Therapeutics Market Drivers
Table 13. Venous thromboembolism(VTE)Therapeutics Market Challenges
Table 14. Venous thromboembolism(VTE)Therapeutics Market Restraints
Table 15. Global Venous thromboembolism(VTE)Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Venous thromboembolism(VTE)Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Venous thromboembolism(VTE)Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Venous thromboembolism(VTE)Therapeutics as of 2020)
Table 18. Ranking of Global Top Venous thromboembolism(VTE)Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Venous thromboembolism(VTE)Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Venous thromboembolism(VTE)Therapeutics Product Solution and Service
Table 22. Date of Enter into Venous thromboembolism(VTE)Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Venous thromboembolism(VTE)Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Venous thromboembolism(VTE)Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Venous thromboembolism(VTE)Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Venous thromboembolism(VTE)Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Venous thromboembolism(VTE)Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Venous thromboembolism(VTE)Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Venous thromboembolism(VTE)Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Venous thromboembolism(VTE)Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Venous thromboembolism(VTE)Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Venous thromboembolism(VTE)Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Venous thromboembolism(VTE)Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Venous thromboembolism(VTE)Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Venous thromboembolism(VTE)Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Venous thromboembolism(VTE)Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Venous thromboembolism(VTE)Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Venous thromboembolism(VTE)Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Venous thromboembolism(VTE)Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Venous thromboembolism(VTE)Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Venous thromboembolism(VTE)Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Venous thromboembolism(VTE)Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Venous thromboembolism(VTE)Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Venous thromboembolism(VTE)Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Venous thromboembolism(VTE)Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Venous thromboembolism(VTE)Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Venous thromboembolism(VTE)Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Venous thromboembolism(VTE)Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Venous thromboembolism(VTE)Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Venous thromboembolism(VTE)Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Venous thromboembolism(VTE)Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Venous thromboembolism(VTE)Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Venous thromboembolism(VTE)Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Venous thromboembolism(VTE)Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Venous thromboembolism(VTE)Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Venous thromboembolism(VTE)Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Venous thromboembolism(VTE)Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Venous thromboembolism(VTE)Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Venous thromboembolism(VTE)Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Venous thromboembolism(VTE)Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Boehringer Ingelheim Company Details
Table 63. Boehringer Ingelheim Business Overview
Table 64. Boehringer Ingelheim Venous thromboembolism(VTE)Therapeutics Product
Table 65. Boehringer Ingelheim Revenue in Venous thromboembolism(VTE)Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Boehringer Ingelheim Recent Development
Table 67. Bayer Company Details
Table 68. Bayer Business Overview
Table 69. Bayer Venous thromboembolism(VTE)Therapeutics Product
Table 70. Bayer Revenue in Venous thromboembolism(VTE)Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Bayer Recent Development
Table 72. Janssen Company Details
Table 73. Janssen Business Overview
Table 74. Janssen Venous thromboembolism(VTE)Therapeutics Product
Table 75. Janssen Revenue in Venous thromboembolism(VTE)Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Janssen Recent Development
Table 77. Bristol-Myers Squibb Company Details
Table 78. Bristol-Myers Squibb Business Overview
Table 79. Bristol-Myers Squibb Venous thromboembolism(VTE)Therapeutics Product
Table 80. Bristol-Myers Squibb Revenue in Venous thromboembolism(VTE)Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Bristol-Myers Squibb Recent Development
Table 82. Pfizer Company Details
Table 83. Pfizer Business Overview
Table 84. Pfizer Venous thromboembolism(VTE)Therapeutics Product
Table 85. Pfizer Revenue in Venous thromboembolism(VTE)Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Pfizer Recent Development
Table 87. Daiichi-Sankyo Company Details
Table 88. Daiichi-Sankyo Business Overview
Table 89. Daiichi-Sankyo Venous thromboembolism(VTE)Therapeutics Product
Table 90. Daiichi-Sankyo Revenue in Venous thromboembolism(VTE)Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Daiichi-Sankyo Recent Development
Table 92. Portola Pharmaceuticals Company Details
Table 93. Portola Pharmaceuticals Business Overview
Table 94. Portola Pharmaceuticals Venous thromboembolism(VTE)Therapeutics Product
Table 95. Portola Pharmaceuticals Revenue in Venous thromboembolism(VTE)Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Portola Pharmaceuticals Recent Development
Table 97. Armetheon Company Details
Table 98. Armetheon Business Overview
Table 99. Armetheon Revenue in Venous thromboembolism(VTE)Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Armetheon Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Venous thromboembolism(VTE)Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Deep Vein Thrombosis(DVT) Features
Figure 3. Pulmonary Embolism(PE) Features
Figure 4. Others Features
Figure 5. Global Venous thromboembolism(VTE)Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Ambulatory Surgery Centers Case Studies
Figure 8. Research Institutes Case Studies
Figure 9. Others Case Studies
Figure 10. Venous thromboembolism(VTE)Therapeutics Report Years Considered
Figure 11. Global Venous thromboembolism(VTE)Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Venous thromboembolism(VTE)Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Venous thromboembolism(VTE)Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Venous thromboembolism(VTE)Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Venous thromboembolism(VTE)Therapeutics Market Share by Players in 2020
Figure 16. Global Top Venous thromboembolism(VTE)Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Venous thromboembolism(VTE)Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Venous thromboembolism(VTE)Therapeutics Revenue in 2020
Figure 18. Global Venous thromboembolism(VTE)Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Venous thromboembolism(VTE)Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Venous thromboembolism(VTE)Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Venous thromboembolism(VTE)Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Venous thromboembolism(VTE)Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Venous thromboembolism(VTE)Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Venous thromboembolism(VTE)Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Venous thromboembolism(VTE)Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Venous thromboembolism(VTE)Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Venous thromboembolism(VTE)Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Venous thromboembolism(VTE)Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Venous thromboembolism(VTE)Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Venous thromboembolism(VTE)Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Venous thromboembolism(VTE)Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Venous thromboembolism(VTE)Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Venous thromboembolism(VTE)Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Venous thromboembolism(VTE)Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Venous thromboembolism(VTE)Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Venous thromboembolism(VTE)Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Venous thromboembolism(VTE)Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Venous thromboembolism(VTE)Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Venous thromboembolism(VTE)Therapeutics Market Share by Region (2016-2027)
Figure 40. China Venous thromboembolism(VTE)Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Venous thromboembolism(VTE)Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Venous thromboembolism(VTE)Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Venous thromboembolism(VTE)Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Venous thromboembolism(VTE)Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Venous thromboembolism(VTE)Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Venous thromboembolism(VTE)Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Venous thromboembolism(VTE)Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Venous thromboembolism(VTE)Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Venous thromboembolism(VTE)Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Venous thromboembolism(VTE)Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Venous thromboembolism(VTE)Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Venous thromboembolism(VTE)Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Venous thromboembolism(VTE)Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Venous thromboembolism(VTE)Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Venous thromboembolism(VTE)Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Venous thromboembolism(VTE)Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Venous thromboembolism(VTE)Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Venous thromboembolism(VTE)Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Boehringer Ingelheim Revenue Growth Rate in Venous thromboembolism(VTE)Therapeutics Business (2016-2021)
Figure 60. Bayer Revenue Growth Rate in Venous thromboembolism(VTE)Therapeutics Business (2016-2021)
Figure 61. Janssen Revenue Growth Rate in Venous thromboembolism(VTE)Therapeutics Business (2016-2021)
Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Venous thromboembolism(VTE)Therapeutics Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in Venous thromboembolism(VTE)Therapeutics Business (2016-2021)
Figure 64. Daiichi-Sankyo Revenue Growth Rate in Venous thromboembolism(VTE)Therapeutics Business (2016-2021)
Figure 65. Portola Pharmaceuticals Revenue Growth Rate in Venous thromboembolism(VTE)Therapeutics Business (2016-2021)
Figure 66. Armetheon Revenue Growth Rate in Venous thromboembolism(VTE)Therapeutics Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---